'Bachelor' couple says it's 'hard to watch the Ozempic craze'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Nuvia Dental Implant Center to Open Seven New Locations in Second Half of 2025
SALT LAKE CITY, Aug. 7, 2025 /PRNewswire/ -- Nuvia Dental Implant Center is expanding access to its full arch dental implant treatment with seven new locations scheduled to open across the U.S. in the second half of 2025. The new centers will be located in: Harrison, NY (September) Fremont, CA (September) Richmond, VA (October) Fort Mill, SC (October) Torrance, CA (October) Fresno, CA (November) Kansas City, KS (November) Each new location will offer Nuvia's Permanent Teeth in 24 Hours — a process that gives patients permanent, custom zirconia teeth just 24 hours after surgery. This life-changing approach removes the need for temporary dentures (healing teeth), multiple fitting appointments, or waiting months for permanent teeth. Making Permanent Teeth in 24 Hours More Accessible Nuvia's process is different from traditional dental implant treatment. While many clinics use temporary sets of teeth and require several appointments over many months, Nuvia provides patients with fixed, permanent teeth the very next day after surgery. This is made possible by combining several parts of the process under one roof: A full team that includes an oral surgeon, a restorative dentist, and a certified nurse anesthetist An in-house lab at every center Advanced 3D planning technology By handling the full process from start to finish (and not relying on outsourcing form 3rd parties), each Nuvia location is able to deliver fast, high-quality results all while prioritizing safety, comfort, and dental implant success. The upcoming locations are expected to help serve both local patients and traveling patients who often struggle to find qualified providers offering full arch dental implants in their area. Changing Lives Across the US With thousands of people across the country struggling with failing or missing teeth, more and more patients are looking for a permanent solution. Many patients have spent years in pain or frustration, trying partials, crowns, root canals, or removable dentures — without long-term success. Nuvia's expanding network of centers is designed to meet that need by bringing a permanent, life-changing solution to more people, closer to where patients live. The new centers also help support out-of-town patients who are looking for 24 hour permanent teeth and are willing to travel to Nuvia. Locations like Torrance, Fremont, and Fresno expand Nuvia's reach in California while cities like Kansas City, Richmond, and Fort Mill provide new access points in the Midwest and Southeast. Each location follows the same process and standards, offering a safe and consistent patient experience no matter where treatment takes place. A Different Kind of Dental Implant Experience Compared to decades-old traditional methods, what Nuvia is doing is truly unique. Backed by years of research and use of the latest technology, Permanent Teeth in 24 Hours is incredibly successful. Nuvia's dental implant success rate in 2024 was 99.13%. This compares impressively to the 93-98% success rate reported in large studies of other dental implant providers. (1). About Nuvia Dental Implant Center Nuvia Dental Implant Center provides full mouth dental implants using a process that delivers permanent teeth just 24 hours after surgery. With in-house labs, a dedicated three-provider team, and advanced planning, Nuvia helps patients get a permanent new smile, designed to last a lifetime without temporary dentures or long delays. To see if you may be a candidate for permanent teeth in 24 hours, take the 60-second quiz Sources:Source: (1) Pjetursson, B. E., Thoma, D., Jung, R., Zwahlen, M., & Zembic, A. (2012). A systematic review of the survival and complication rates of implant-supported fixed dental prostheses (FDPs) after a mean observation period of at least 5 years. Clinical Oral Implants Research, 23(Suppl 6), 22-38. Media Contact: marketing@ View original content to download multimedia: SOURCE Nuvia Dental Implant Center Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
Why Eli Lilly (LLY) Shares Are Getting Obliterated Today
What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 13.9% in the afternoon session after its oral weight-loss drug trial results disappointed investors, overshadowing an otherwise strong quarterly earnings report and guidance increase. The pharmaceutical company announced late-stage trial data for its oral weight-loss pill, orforglipron, which showed an average weight loss of 12.4%. This figure fell short of analyst expectations, which anticipated a result closer to 15%, and also trailed the effectiveness of a rival treatment from Novo Nordisk. This disappointing development overshadowed Eli Lilly's strong second-quarter financial report, where the company beat earnings estimates and raised its full-year sales and profit forecasts. Investors reacted to the perceived setback in the highly competitive weight-loss drug market, triggering the most significant single-day stock drop in over two decades. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Eli Lilly? Access our full analysis report here, it's free. What Is The Market Telling Us Eli Lilly's shares are somewhat volatile and have had 10 moves greater than 5% over the last year. But moves this big are rare even for Eli Lilly and indicate this news significantly impacted the market's perception of the business. The previous big move we wrote about was 9 days ago when the stock dropped 4.3% on the news that its key competitor in the weight-loss drug market, Novo Nordisk, lowered its sales and profit growth forecasts for 2025. The lowered guidance from the Danish pharmaceutical giant cast a shadow over the high-growth weight-loss drug sector. This was the second time this year Novo Nordisk had reduced its outlook, which amplified investor concerns about the market's future performance. Compounding the issue, Eli Lilly also faced headwinds as CVS Caremark implemented coverage restrictions on its popular weight-loss drug, Zepbound, in response to surging demand. The combination of a major competitor's weakened forecast and specific access challenges for one of Lilly's key products appeared to prompt the sell-off. Eli Lilly is down 17.3% since the beginning of the year, and at $643.46 per share, it is trading 33% below its 52-week high of $960.02 from August 2024. Investors who bought $1,000 worth of Eli Lilly's shares 5 years ago would now be looking at an investment worth $4,208. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Gizmodo
21 minutes ago
- Gizmodo
Woman Diagnosed with Malaria in Washington May Be State's First Locally Acquired Case
Washington state officials have revealed that a local woman has been diagnosed with malaria, which, if confirmed, would mark the first known case of the disease being acquired in the state. The woman was diagnosed with malaria, a mosquito-borne illness caused by a parasite, on August 2, according to the officials. State and federal public health agencies are working to confirm the source of the infection, according to a statement published on Wednesday. Officials believe that the infection may have been transmitted by a mosquito that bit someone else who already had a travel-associated case of malaria. The woman is currently receiving treatment and is being closely monitored. Symptoms of the disease include fever, chills, body aches, fatigue, vomiting, and diarrhea. It can take up to 30 days for an infected person to start showing symptoms. Cases of malaria in the U.S. are typically linked to travel—mainly to visitors with ties to sub-Saharan African countries—and the disease is not considered endemic to the U.S. In fact, the U.S. effectively eradicated malaria in the 1950s thanks to aggressive control measures, including pesticides and improved drainage. But the Anopheles mosquito which transmits malaria lives all over the country: If they bite someone infected with the disease, the bugs could feasibly transmit the parasite that causes malaria to other people in the area. Between 20-70 cases of malaria are recorded in Washington each year and there are typically around 2,000 cases annually across the U.S., according to official estimates. While many are linked to travel, there has been a recent uptick in locally-acquired infections. In 2023, the U.S. experienced its first locally acquired malaria case in 20 years. And between May and October of that year, 10 such cases were reported across Florida, Texas, Maryland, and Arkansas. Climate change may be driving the incidence of local malaria infections up: The parasite that causes malaria needs warm temperatures to thrive, and research suggests more cases of the disease could arise in previously malaria-free areas as the planet warms. The U.S. has historically been the top donor nation to global efforts to combat malaria, according to health nonprofit KFF. But those initiatives took a hit when the Trump administration slashed the country's foreign aid programs earlier this year, including most of the work of the President's Malaria Initiative—a USAID program launched in 2005 focused on reducing malaria in countries where the disease is endemic. As part of the investigation in Washington, officials are working with the U.S. Department of Health to trap and test mosquitoes. Local authorities have stressed that people in the area of the state where the woman was infected remain at very low risk of contracting malaria. 'The risk of getting infected with malaria in Pierce County remains very low,' James Miller, health officer for Tacoma-Pierce County, said in a statement. 'Malaria is a rare disease overall in the United States—and the vast majority of cases in the United States occur following exposures in countries with ongoing transmission.'
